Portolan Capital Management, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Portolan Capital Management, LLC
- $1.32 Billion
- Q4 2024
A detailed history of Portolan Capital Management, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Portolan Capital Management, LLC holds 131,123 shares of AMPH stock, worth $4.1 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
131,123
Previous 327,764
59.99%
Holding current value
$4.1 Million
Previous $15.9 Million
69.4%
% of portfolio
0.37%
Previous 1.27%
Shares
11 transactions
Others Institutions Holding AMPH
# of Institutions
275Shares Held
35.2MCall Options Held
26.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY5.94MShares$186 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$84.9 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$57.6 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$49.9 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$43 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.53B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...